Trial Profile
COMPARISON OF SWITCHING PRASUGREL OR TICAGRELOR IN ELDERLY PATIENTS WITH CORONARY ARTERY DISEASE ON CLOPIDOGREL THERAPY WITH HIGH PLATELET REACTIVITY: A RANDOMIZED PHARMACODYNAMIC STUDY EFECTOS DEL CAMBIO A PRASUGREL O TICAGRELOR EN PACIENTES ANCIANOS CON ENFERMEDAD CORONARIA EN TRATAMIENTO CRONICO CON CLOPIDOGREL Y ELEVADA REACTIVIDAD PLAQUETARIA: ESTUDIO FARMACODINAMICO ALEATORIZADO
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2016
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms ESTUDIO PRATICEL; PRATICEL STUDY
- 04 Nov 2016 Status changed from recruiting to discontinued.
- 30 Jun 2014 New trial record